XELJANZ 11 mg film-coated tablets

Licence status
Authorised: 16/12/2019
Active substances
TOFACITINIB
Dosage Form
Prolonged-release tablet
Licence number
EU/1/17/1178/010-013
Licence holder
Pfizer Europe MA EEIG

Product documents

Licence information

ATC code
L01XC32 atezolizumab, L04AA Selective immunosuppressants
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/12/2019

Educational materials for healthcare professionals

Educational materials for patients